NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$14.05
-0.0500 (-0.355%)
At Close: Apr 30, 2024
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
01:58pm, Wednesday, 23'rd Nov 2022 Benzinga
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
12:05pm, Wednesday, 23'rd Nov 2022 Benzinga
Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
1
2
0
Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO
03:05pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Teva Pharmaceutical (TEVA) appoints Richard Francis as the company's new president and chief executive officer, effective from Jan 1, 2023.
C-Suite Shakeup Pressures Teva Pharmaceutical Stock
10:49am, Monday, 21'st Nov 2022
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is down 2.1% at $8.54 at last check, after the company named former Novartis (NVS) and Biogen (BIIB) executive Richard Francis as its new chief executi
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO
10:37am, Monday, 21'st Nov 2022
Teva Pharmaceuticals (NYSE: TEVA ) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. Francis will take over as the president and CEO of Teva Pharm
Teva names former Sandoz chief Richard Francis as new CEO
07:16am, Monday, 21'st Nov 2022
Teva Pharmaceutical Industries Ltd. TEVA, +0.93% on Monday said its current CEO Kåre Schultz will retire on Dec. 31.
Teva Pharmaceutical: Warren Buffett Likely Made A Mistake Selling Shares
03:55pm, Friday, 18'th Nov 2022
Teva Pharmaceutical was able to achieve a nationwide settlement to the opioid crisis, proving the ability of the company's management to overcome difficulties. Teva Pharmaceutical's provision for lega
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
12:07pm, Monday, 14'th Nov 2022 Benzinga
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at
Adding $100 to These 5 Stocks Would Be a Genius Move Right Now
10:21am, Wednesday, 09'th Nov 2022 The Motley Fool
You don't need a large pile of cash to begin building wealth on Wall Street.
Adding $100 to These 5 Stocks Would Be a Genius Move Right Now
05:21am, Wednesday, 09'th Nov 2022
You don't need a large pile of cash to begin building wealth on Wall Street.
Why Teva Stock Stumbled Again on Friday
10:03pm, Friday, 04'th Nov 2022 The Motley Fool
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.
Why Teva Stock Stumbled Again on Friday
06:03pm, Friday, 04'th Nov 2022
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.
TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down
12:03pm, Friday, 04'th Nov 2022
TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.
Why Teva Stock Sank On Thursday
09:57pm, Thursday, 03'rd Nov 2022 The Motley Fool
There were two major developments with the company, both of which involved piles of money.
Why Teva Stock Sank On Thursday
05:57pm, Thursday, 03'rd Nov 2022
There were two major developments with the company, both of which involved piles of money.
